Cardiovascular Business
11 FOLLOWERS
Cardiovascular Business is a news, business, and technology source for cardiovascular medicine. We focus on the business and economics behind the foremost clinical, interventional, surgical, and information technologies as well as pharmaceuticals and related products that are key to achieving a successful integrated cardiovascular practice.
Cardiovascular Business
1w ago
Stroke is typically seen as the biggest danger for patients after they receive an AFib diagnosis. This study, however, suggests heart failure could be an even bigger threat ..read more
Cardiovascular Business
1w ago
The 65-year-old male patient presented with a long medical history and many comorbidities, making surgery too risky ..read more
Cardiovascular Business
1w ago
Alexander Fanaroff, MD, said the late-breaking BE ACTIVE clinical trial presented at ACC.24 offers a blueprint for how to get patients to be more physically active ..read more
Cardiovascular Business
3w ago
Day 1 at ACC.24: Late-breakers examine potential new heart attack, heart failure treatments ..read more
Cardiovascular Business
3w ago
Weight loss drug semaglutide benefits obese patients presenting with HFpEF, type 2 diabetes ..read more
Cardiovascular Business
3w ago
ACC.24: Impella CP boosts survival for patients with STEMI-related cardiogenic shock ..read more
Cardiovascular Business
1M ago
Polyethylene was present in 58.4% of patients, and polyvinyl chloride was present in 12.1%. The presence of either one was associated with an increased risk of heart attack, stroke or death. ..read more
Cardiovascular Business
1M ago
The Evolut FX+ TAVR system includes an updated diamond-shaped frame, which was made four times larger than previous models to offer improved coronary access. It was also designed to provide more space for operators to guide and maneuver the catheter during procedures ..read more
Cardiovascular Business
1M ago
Hoping to gain a better understanding of how TAVR may impact a patient’s long-term cardiovascular health, researchers explored data from more than 200,000 patients and shared their findings in ..read more
Cardiovascular Business
1M ago
Only orthopedic surgeons and neurologists/psychiatrists received more industry payments from 2013 to 2022 than cardiologists. Also, the two prescription medications associated with the most physician payments were a blood thinner and an anticoagulant. ..read more